Publications-ELK Biotechnology CO.,Ltd.

Technical

IF：3.2 Date：2025-02-18

MOLECULAR IMMUNOLOGY

UBE2I depletion regulated tumor-associated macrophage polarization into M1 type through reprogramming glycolysis and increases immunotherapy efficacy of anti-PD-L1 in ovarian cancer

Products： EP013
IF：3.2 Date：2025-04-17

Metabolic Brain Disease

Protective mechanism of apigenin in proton pump inhibitor-associated progressive cognitive impairment in adult zebrafish via targeting GSK-3β pathway

Products： ELK8505、 ELK8508、 ELK8512
IF：3.2 Date：2025-04-17

Metabolic Brain Disease

Probiotics ameliorates hypothalamic amenorrhea in a rat model of PCOS

Products： ELK0030、 ELK1315、 ELK2367、 ELK5453
IF：3.2 Date：2025-04-17

lift

Antitumor Effects of Quercetin and Luteolin in A375 Cutaneous Melanoma Cell Line Are Mediated by Upregulation of P-ERK, c-Myc, and the Upstream GPER

Products： EA053、 EA331、 ES11471

< Page of 377 >